Cargando…
Prospects of Therapeutic Target and Directions for Ischemic Stroke
Stroke is a serious, adverse neurological event and the third leading cause of death and disability worldwide. Most strokes are caused by a block in cerebral blood flow, resulting in neurological deficits through the death of brain tissue. Recombinant tissue plasminogen activator (rt-PA) is currentl...
Autores principales: | Kim, Jung Hak, Kim, So Young, Kim, Bokyung, Lee, Sang Rae, Cha, Sang Hoon, Lee, Dong Seok, Lee, Hong Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065883/ https://www.ncbi.nlm.nih.gov/pubmed/33916253 http://dx.doi.org/10.3390/ph14040321 |
Ejemplares similares
-
Therapeutically Targeting Neuroinflammation and Microglia after Acute Ischemic Stroke
por: Lee, Youngjeon, et al.
Publicado: (2014) -
L-myc Gene Expression in Canine Fetal Fibroblasts Promotes Self-Renewal Capacity but Not Tumor Formation
por: Kim, So Hee, et al.
Publicado: (2021) -
Assessment of Hand Motor Function in a Non-human Primate Model of Ischemic Stroke
por: Won, Jinyoung, et al.
Publicado: (2020) -
Factors Associated with Ischemic Stroke on Therapeutic Anticoagulation in Patients with Nonvalvular Atrial Fibrillation
por: Kim, Young Dae, et al.
Publicado: (2015) -
Impact of Osteoporosis Pharmacotherapy on Functional Outcomes after Ischemic Stroke
por: Sohn, Jong-Hee, et al.
Publicado: (2023)